Michael James Newman serves as Executive at Indaptus Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Michael James Newman has executed 3 insider transactions totaling $100.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 22, 2025 involved receiving (via award) 52,204 shares valued at $106.0K.
Michael James Newman currently holds 101,074 shares of Indaptus Therapeutics, Inc. (INDP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael James Newman has been a net seller of INDP stock. They have purchased $0 and sold $100.0K worth of shares.
Michael James Newman's most recent insider trade was on Dec 22, 2025, when they sold 52,204 shares at $2.03 per share.
Get notified when new Form 4 filings are submitted
| $5.00 |
| Discretionary |
| Jan 31, 2022 | INDP | $29.4K | Sale | 5,870 | $5.00 | Discretionary |